MENU
TVTX
AS OF
Feb 3 closing price
Price
$32.84
Change
+$6.77 (+25.97%)
Capitalization
2.94B
15 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TVTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Travere Therapeutics (TVTX) Earnings Date & Reports

Travere Therapeutics Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

TVTX is expected to report earnings to fall 106.80% to -4 cents per share on February 19

Travere Therapeutics TVTX Stock Earnings Reports
Q4'25
Est.
$-0.04
Q3'25
Beat
by $0.88
Q2'25
Beat
by $0.16
Q1'25
Beat
by $0.36
Q4'24
Beat
by $0.17
The last earnings report on October 30 showed earnings per share of 58 cents, beating the estimate of -28 cents. With 1.75M shares outstanding, the current market capitalization sits at 2.94B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
TVTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TVTX showed earnings on October 30, 2025. You can read more about the earnings report here.
View AI-Driven Trading for TVTX
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which develops pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3611 Valley Centre Drive
Phone
+1 888 969-7879
Employees
380
Web
https://www.travere.com